| 1 |
29427069 | New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. | 2018 Feb 9 |
1 |
| 2 |
24484975 | The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. | 2014 |
1 |
| 3 |
23875705 | Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. | 2013 Oct |
1 |
| 4 |
20036131 | Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters. | 2010 Jan 15 |
3 |
| 5 |
15331654 | Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum. | 2005 Jan |
1 |
| 6 |
11841781 | A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. | 2002 Jan 15 |
3 |
| 7 |
9648873 | Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine. | 1998 Jul |
1 |